TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.90$ +3.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +404.0% +597.5% -18.9% +72.7% -19.9% +32.3% -19.4%
– +355.3% +751.0% -22.9% +46.8% -29.8% +8.0% +3.4%
– +162.0% +369.2% -37.1% -38.3% -17.2% -10.2% +42.2%
– +370.2% +751.3% -24.4% +47.9% -29.5% +7.7% +3.3%
– – – – – -84.6% +0.0% +900.0%
– – – – – – – –
– +694.3% +74.6% -28.0% +381.5% – – –
– +392.6% -77.8% +39.6% +339.2% +4.8% -11.7% -1.4%
– +295.3% +7.6% +46.6% +70.3% +5.8% -18.9% +17.7%
– – -7.5% +77.2% +71.1% +42.8% -0.3% +13.9%
– +412.6% -37.5% -5.4% +58.4% +108.1% -82.6% +227.4%
– – – -21.9% +48.3% -26.6% +49.3% -23.4%
– – – – – – – –
– -82.1% +254.0% +3.3% +32.8% +12.3% +38.5% +9.0%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?